NCT00731952
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- University of Virginia Charlottesville, Virginia, United States
Clinical trial condition
Carcinoma, Non-Small-Cell Lung
Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.
4,700 public trials
1,041 recruiting studies
Carcinoma, Non-Small-Cell Lung trial results
NCT00188214
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- University Health Network Toronto, Ontario, Canada
NCT01493843
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Alabama Oncology Birmingham, Alabama, United States
- Highlands Oncology Group Rogers, Arkansas, United States
- cCare Encinitas, California, United States
- Kaiser Permanente - Oakland Oakland, California, United States
NCT00408460
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +15 more
- Locations
-
- University of New Mexico Cancer Center Albuquerque, New Mexico, United States
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
Completed
Ph II Gemcitabine, Erlotinib, and Gemcitabine With Erlotinib/Elderly Patients W/ IIIB/IV NSCLC
NCT00283244
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Highlands Oncology Group - Fayetteville Fayetteville, Arkansas, United States
- Summit Cancer Care Savannah, Georgia, United States
- Evanston Hospital Evanston, Illinois, United States
- Hackensack University Medical Center Cancer Center Hackensack, New Jersey, United States
NCT01999673
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
- Locations
-
- Peregrine Pharmaceuticals Investigational Site Huntsville, Alabama, United States
- Peregrine Pharmaceuticals Investigational Site Chandler, Arizona, United States
- Peregrine Pharmaceuticals Investigational Site Glendale, Arizona, United States
- Peregrine Pharmaceuticals Investigational Site Greenbrae, California, United States
NCT00899028
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States
- Vanderbilt-Ingram Cancer Center at Franklin Nashville, Tennessee, United States
- Veterans Affairs Medical Center - Nashville Nashville, Tennessee, United States
- Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
NCT01138163
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Ironwood Cancer and Research Center Chandler, Arizona, United States
- South Bay Hematology Oncology Campbell, California, United States
- Medical Oncology Care Associates Orange, California, United States
- American Institute of Research Whittier, California, United States
NCT01160601
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Ironwood Cancer and Research Center Chandler, Arizona, United States
- Baptist Clinical Research Jonesboro, Arkansas, United States
- American Institute of Research Whittier, California, United States
- Baptist Cancer Institute Jacksonville, Florida, United States
Completed
Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors
NCT00004095
- Conditions
- Adenocarcinoma, Bladder Cancer, Breast Cancer, +49 more
- Locations
-
- Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States